Literature DB >> 34656473

CXCR4-Targeted Imaging of Post-Infarct Myocardial Tissue Inflammation: Prognostic Value After Reperfused Myocardial Infarction.

Rudolf A Werner, Tobias Koenig, Johanna Diekmann, Arash Haghikia, Thorsten Derlin, James T Thackeray, L Christian Napp, Hans-Jürgen Wester, Tobias L Ross, Andreas Schaefer, Johann Bauersachs, Frank M Bengel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34656473     DOI： 10.1016/j.jcmg.2021.08.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  5 in total

1.  Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System In Vivo to Treat Heart Disease.

Authors:  Joel G Rurik; Jonathan A Epstein
Journal:  DNA Cell Biol       Date:  2022-04-20       Impact factor: 3.550

2.  CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection.

Authors:  Andreas K Buck; Rudolf A Werner; Alessandro Lambertini; Philipp E Hartrampf; Takahiro Higuchi; Sebastian E Serfling; Patrick Meybohm; Andreas Schirbel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-12       Impact factor: 10.057

Review 3.  Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.

Authors:  Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs
Journal:  Eur Heart J       Date:  2022-07-14       Impact factor: 35.855

Review 4.  CXCR4-targeted theranostics in oncology.

Authors:  Andreas K Buck; Sebastian E Serfling; Thomas Lindner; Heribert Hänscheid; Andreas Schirbel; Stefanie Hahner; Martin Fassnacht; Hermann Einsele; Rudolf A Werner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-08       Impact factor: 10.057

5.  Characterizing the transition from immune response to tissue repair after myocardial infarction by multiparametric imaging.

Authors:  Annika Hess; Tobias Borchert; Tobias L Ross; Frank M Bengel; James T Thackeray
Journal:  Basic Res Cardiol       Date:  2022-03-11       Impact factor: 12.416
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.